cbdMD Inc (YCBD)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX
Market Cap: $5.02M
Last updated: Nov 17, 2026 at 11:03 AM ET
cbdMD Inc (YCBD) Earnings: Report Dates and Results
cbdMD (YCBD) is expected to report earnings on Dec 18, 2026. In the quarter ended Jun 30, 2026, cbdMD reported EPS of -$0.11, below the -$0.03 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
YCBD has an expected report date of Dec 18, 2026.
YCBD Earnings Call
The latest YCBD earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptEarnings History
Of the 28 quarters below that had an estimate, YCBD beat 9 and missed 19. Revenue for the quarter ended Jun 30, 2026 was $5.55M, up 20.4% from $4.61M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.11 | -$0.03 | -$0.03 - -$0.03 | -266.67% | Miss | N/A | 1 | 1 up, 0 down | Aug 13, 2026 | $5.55M |
| Mar 31, 2026 | -$0.08 | -$0.05 | -$0.05 - -$0.05 | -60.00% | Miss | N/A | 1 | 1 up, 0 down | May 14, 2026 | $5.64M |
| Dec 31, 2025 | -$0.04 | -$0.06 | N/A | +33.33% | Beat | N/A | 1 | 0 up, 0 down | Feb 17, 2026 | $5.02M |
| Sep 30, 2025 | -$0.08 | -$0.07 | -$0.07 - -$0.07 | -14.29% | Miss | N/A | 1 | 1 up, 0 down | Dec 19, 2025 | $4.72M |
| Jun 30, 2025 | -$0.21 | -$0.16 | N/A | -31.25% | Miss | N/A | N/A | 0 up, 0 down | Aug 14, 2025 | $4.61M |
| Mar 31, 2025 | -$1.90 | -$1.60 | N/A | -18.75% | Miss | N/A | N/A | 0 up, 0 down | May 15, 2025 | $4.75M |
| Dec 31, 2024 | -$1.76 | -$2.96 | N/A | +40.54% | Beat | N/A | N/A | 0 up, 0 down | Feb 13, 2025 | $5.11M |
| Sep 30, 2024 | -$0.29 | -$0.45 | N/A | +34.82% | Beat | N/A | N/A | 0 up, 0 down | Dec 27, 2024 | $4.56M |
| Jun 30, 2024 | -$1.20 | -$4.96 | -$4.96 - -$4.96 | +75.81% | Beat | N/A | 1 | 0 up, 0 down | Aug 14, 2024 | $5.17M |
| Mar 31, 2024 | -$10.80 | -$6.00 | -$6.00 - -$6.00 | -80.00% | Miss | N/A | 1 | 0 up, 0 down | May 15, 2024 | $4.38M |
| Dec 31, 2023 | -$5.21 | -$5.92 | -$5.92 - -$5.92 | +11.99% | Beat | N/A | 1 | 0 up, 0 down | Jan 29, 2024 | $5.38M |
| Sep 30, 2023 | -$1.21 | -$0.76 | N/A | -59.21% | Miss | N/A | N/A | 0 up, 0 down | Dec 22, 2023 | $5.71M |
| Jun 30, 2023 | -$9.28 | -$28.80 | N/A | +67.78% | Beat | N/A | N/A | 0 up, 0 down | Aug 10, 2023 | $6.12M |
| Mar 31, 2023 | -$0.03 | -$0.04 | N/A | +25.00% | Beat | N/A | N/A | 0 up, 0 down | May 15, 2023 | $6.24M |
| Dec 31, 2022 | -$28.80 | -$126.00 | N/A | +77.14% | Beat | N/A | N/A | 0 up, 0 down | Feb 13, 2023 | $6.09M |
| Sep 30, 2022 | -$0.26 | -$0.03 | N/A | -759.00% | Miss | N/A | N/A | 0 up, 0 down | Dec 15, 2022 | $7.86M |
| Jun 30, 2022 | -$198.00 | -$18.00 | N/A | -1000.00% | Miss | N/A | N/A | 0 up, 0 down | Aug 11, 2022 | $8.59M |
| Mar 31, 2022 | -$36.00 | -$14.40 | N/A | -150.00% | Miss | N/A | N/A | 0 up, 0 down | May 13, 2022 | $9.63M |
| Dec 31, 2021 | -$126.00 | -$14.40 | N/A | -775.00% | Miss | N/A | 1 | 0 up, 0 down | Feb 10, 2022 | $9.32M |
| Sep 30, 2021 | -$0.07 | -$0.04 | -$0.07 - -$0.02 | -75.00% | Miss | N/A | 2 | 0 up, 0 down | Dec 17, 2021 | $9.79M |
| Jun 30, 2021 | -$42.12 | -$21.60 | -$21.62 - -$7.21 | -95.00% | Miss | N/A | 2 | N/A | Aug 12, 2021 | $10.56M |
| Mar 31, 2021 | -$28.30 | -$14.40 | -$14.41 - -$7.21 | -96.53% | Miss | N/A | 2 | N/A | May 12, 2021 | $11.80M |
| Dec 31, 2020 | -$10.62 | -$3.60 | -$7.21 - -$3.60 | -195.00% | Miss | N/A | 2 | N/A | Feb 9, 2021 | $12.33M |
| Sep 30, 2020 | -$0.14 | -$0.01 | -$0.01 - -$0.01 | N/A | N/A | -117.7% | 1 | N/A | Dec 22, 2020 | $11.70M |
| Jun 30, 2020 | -$10.04 | -$9.00 | -$18.02 - -$7.21 | -11.56% | Miss | N/A | 2 | N/A | Aug 12, 2020 | $10.64M |
| Mar 31, 2020 | -$55.87 | -$25.20 | -$46.85 - -$14.41 | -121.71% | Miss | N/A | 3 | N/A | May 18, 2020 | $9.40M |
| Dec 31, 2019 | -$51.05 | -$46.62 | -$68.47 - -$32.43 | -9.50% | Miss | N/A | 3 | N/A | Feb 13, 2020 | $10.15M |
| Sep 30, 2019 | $0.79 | -$0.17 | -$0.18 - -$0.17 | +564.71% | Beat | N/A | 2 | N/A | Dec 18, 2019 | $9.54M |
| Jun 30, 2019 | -$428.40 | -$36.00 | N/A | N/A | N/A | -1428100.0% | 1 | N/A | Aug 14, 2019 | $8.01M |
| Mar 31, 2019 | -$31.10 | -$18.00 | N/A | -72.78% | Miss | -18394.1% | 1 | N/A | May 15, 2019 | $5.64M |
| Dec 31, 2018 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 14, 2019 | $465687 |
| Sep 30, 2018 | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 12, 2018 | N/A |
| Jun 30, 2018 | $0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2018 | $3.20M |
| Mar 31, 2018 | $0.17 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2018 | $3.08M |
| Dec 31, 2017 | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 14, 2018 | $2.09M |
| Sep 30, 2017 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 26, 2017 | N/A |
| Mar 31, 2017 | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 4, 2017 | $5.23M |
Annual EPS
EPS for the fiscal year ended Sep 30, 2026 was -$0.23, after -$3.95 the year before. It was -$0.16 for the year ended Sep 30, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | -$0.23 | N/A |
| Sep 30, 2025 | -$3.95 | N/A |
| Sep 30, 2024 | -$17.50 | N/A |
| Sep 30, 2023 | -$39.32 | N/A |
| Sep 30, 2022 | -$360.26 | N/A |
| Sep 30, 2021 | -$81.11 | N/A |
| Sep 30, 2020 | -$117.10 | N/A |
| Sep 30, 2019 | -$458.77 | N/A |
| Sep 30, 2018 | -$0.07 | N/A |
| Sep 30, 2017 | -$0.16 | N/A |
Earnings Calls
The 6 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 4,200 words across 5 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q2 | Jun 30, 2026 | 4,173 | 5 | |
| 2026Q1 | Mar 31, 2026 | 2,152 | 4 | |
| 2025Q4 | Dec 31, 2025 | 3,714 | 6 | |
| 2025Q2 | Jun 30, 2025 | 3,263 | 5 | |
| 2025Q1 | Mar 31, 2025 | 2,944 | 5 | |
| 2024Q3 | Sep 30, 2024 | 2,732 | 5 |
2026Q2 Earnings Call
Opening remarks
Bradley Whitford Chief Accounting Officer Thank you, Operator, and thank you all for joining cbdMD's March 31, 2026, Second Quarter of Fiscal 2026 Earnings Call and Update. On the call today, we also have Ronan Kennedy, our Chief Executive Officer and Chief Financial Officer. We'd like to remind everyone that various remarks about future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. cbdMD cautions that these forward-looking statements are subject to risks and uncertainties that may cause our actual results to differ materially from those indicated, including risks described in the company's annual report on Form 10-K for the second quarter ended March 31, 2026, and our other filings with the SEC, all of which can be reviewed on the company's website at www.cbdmd.com or on the SEC's website at www.sec.gov. Any forward-looking statements made on this conference call speak only as of today's date, Thursday, May 14, 2026, and cbdMD does not intend to update any of these forward-looking statements to reflect events or circumstances that would occur after today's date, except as may be required by federal securities laws. With that, I'd like to turn the call over to Ronan.
Ronan Kennedy CEO & CFO Good afternoon, everyone, and thank you for joining us. The second quarter of fiscal 2026 was another step forward for cbdMD and one of the most active quarters we've had in years, both operationally and across the regulatory landscape we operate in. Let me start with the headline. We delivered another consecutive quarter of sequential revenue growth, with net sales of $5.6 million. That's up 19% year-over-year and 12% sequentially from the first quarter of 2026. Importantly, that growth was not solely driven by our acquisition of Bluebird Botanicals. Excluding Bluebird, our core business grew approximately $0.5 million versus the prior year and approximately $300,000 sequentially. And even excluding Bluebird, our core revenue this quarter was the highest quarterly revenue we've generated since our first fiscal quarter in 2024, the December 2023 quarter. That continued core growth quarter after quarter is the most important indicator that the reset work we've done over the past several years is showing through in results. From a channel perspective, direct-to-consumer remained our largest channel at approximately 67% of revenue, with wholesale growing to 33% of revenue. Wholesale was up 65% year-over-year reflecting continued execution in our core cbdMD brand and ongoing progress with our Oasis TSC beverage brand. In mid-January, we closed our acquisition of the assets of Bluebird Botanicals, a respected and long-standing CBD brand.
Frequently Asked Questions About YCBD
When is cbdMD's next earnings date?
cbdMD's next earnings report is expected for Dec 18, 2026.
Did YCBD beat earnings estimates last quarter?
No. cbdMD reported EPS of -$0.11 for the quarter ended Jun 30, 2026, below the -$0.03 estimate by 266.67%.
What EPS do analysts expect from YCBD next quarter?
The consensus EPS estimate for cbdMD for the quarter ended Sep 30, 2026 is -$0.09 from 3 analysts, with estimates from -$0.09 to -$0.09.
How often does YCBD beat earnings estimates?
cbdMD beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -35.28%.
YCBD pages: Overview, Earnings, Forecast, Financials, Competitors